CEACAM5 and neoplasm: Laboratory tests revealed elevated tumor markers [carcinoembryonic antigen (CEA) 17.2 ng/mL, CA-199–58 U/mL] and decreased hemoglobin (10.6 g/dL), with otherwise normal findings.